Roth Capital Boosts Earnings Estimates for Aspen Aerogels

Aspen Aerogels, Inc. (NYSE:ASPN) – Equities research analysts at Roth Capital raised their Q1 2025 EPS estimates for Aspen Aerogels in a report issued on Friday, November 8th. Roth Capital analyst C. Moore now expects that the construction company will earn $0.04 per share for the quarter, up from their prior forecast of $0.02. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.11 per share. Roth Capital also issued estimates for Aspen Aerogels’ Q3 2025 earnings at $0.23 EPS.

Several other brokerages also recently weighed in on ASPN. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a research note on Thursday, October 31st. TD Cowen upped their price objective on shares of Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a report on Tuesday, August 20th. HC Wainwright reaffirmed a “buy” rating and issued a $30.00 price objective on shares of Aspen Aerogels in a research report on Wednesday, October 16th. Piper Sandler lowered their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Finally, Roth Mkm decreased their price target on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Aspen Aerogels currently has a consensus rating of “Moderate Buy” and a consensus target price of $28.70.

Aspen Aerogels Stock Performance

Shares of ASPN stock opened at $15.80 on Monday. Aspen Aerogels has a 12-month low of $8.79 and a 12-month high of $33.15. The business’s fifty day simple moving average is $22.87 and its 200-day simple moving average is $24.74. The company has a current ratio of 3.46, a quick ratio of 2.82 and a debt-to-equity ratio of 0.23. The company has a market cap of $1.22 billion, a PE ratio of 1,581.58 and a beta of 2.21.

Insider Buying and Selling

In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the company’s stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the sale, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at approximately $626,610.60. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Donald R. Young sold 63,355 shares of the company’s stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now owns 483,640 shares in the company, valued at approximately $14,523,709.20. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Aspen Aerogels

Several large investors have recently made changes to their positions in ASPN. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Aspen Aerogels by 10.3% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,310 shares of the construction company’s stock worth $341,000 after purchasing an additional 1,339 shares during the period. nVerses Capital LLC increased its position in shares of Aspen Aerogels by 45.0% in the third quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock valued at $161,000 after buying an additional 1,800 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in Aspen Aerogels by 15.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 14,580 shares of the construction company’s stock worth $257,000 after acquiring an additional 1,938 shares during the period. Point72 Hong Kong Ltd acquired a new position in shares of Aspen Aerogels during the 2nd quarter worth about $84,000. Finally, Quent Capital LLC acquired a new position in shares of Aspen Aerogels during the third quarter valued at approximately $118,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.